This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hong, F. D. Articles by Clayman, G. L. Search for Related Content PubMed PubMed Citation Articles by Hong, F. D. Articles by Clayman, G. L.

Isolation of a Peptide for Targeted Drug Delivery into Human Head and Neck Solid Tumors¹

The Departments of Head and Neck Surgery (F. D. H., G. L. C.) and Cancer Biology (G. L. C.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Lack of tumor specificity remains a major problem with chemotherapies in that side effects prevent the delivery of dosages of drugs that are required to eliminate tumors. In this report, we describe the isolation of a 12-mer peptide (HN-1), with 1% of the mass of typical antibodies, that meets several criteria for targeted drug delivery into a solid tumor. First, internalization of HN-1 by human head and neck squamous cell cancer (HNSCC) cells suggests that HN-1 is capable of translocating drugs across cell membranes. Second, HN-1 appears to be HNSCC-specific, given its reduced uptake by nonmalignant human oral keratinocytes and other types of human cells, its preferential binding to primary HNSCC, and its localization to HNSCC-derived xenografts. Third, the presence of HN-1 within HNSCC xenografts suggests that it is capable of penetrating tumor tissues. Our results establish the utility of tumor-specific peptides for targeted drug delivery into solid tumors.

This article has been cited by other articles:

				S. Nishimura, S. Takahashi, H. Kamikatahira, Y. Kuroki, D. E. Jaalouk, S. O'Brien, E. Koivunen, W. Arap, R. Pasqualini, H. Nakayama, et al. Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells J. Biol. Chem., April 25, 2008; 283(17): 11752 - 11762. [Abstract] [Full Text] [PDF]

				S.-M. Lee, E.-J. Lee, H.-Y. Hong, M.-K. Kwon, T.-H. Kwon, J.-Y. Choi, R.-W. Park, T.-G. Kwon, E.-S. Yoo, G.-S. Yoon, et al. Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display Mol. Cancer Res., January 1, 2007; 5(1): 11 - 19. [Abstract] [Full Text] [PDF]

				T. Nakamura, K. Sato, and H. Hamada Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber J. Virol., February 15, 2003; 77(4): 2512 - 2521. [Abstract] [Full Text] [PDF]

				S. Zitzmann, V. Ehemann, and M. Schwab Arginine-Glycine-Aspartic Acid (RGD)-Peptide Binds to Both Tumor and Tumor-Endothelial Cells in Vivo Cancer Res., September 15, 2002; 62(18): 5139 - 5143. [Abstract] [Full Text] [PDF]

				J. C. Mai, Z. Mi, S.-H. Kim, B. Ng, and P. D. Robbins A Proapoptotic Peptide for the Treatment of Solid Tumors Cancer Res., November 1, 2001; 61(21): 7709 - 7712. [Abstract] [Full Text] [PDF]